The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biomaterials

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.biomaterials.2010.08.078PMID 20926130PMCID PMC3576133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals.

  2009cited by this paper
• Templated spherical high density lipoprotein nanoparticles.

  2009cited by this paper
• Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform.

  2008cited by this paper
• Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes

  2008cited by this paper
• Atheroprotective effects of HDL: beyond reverse cholesterol transport.

  2008cited by this paper
• Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins

  2008cited by this paper
• Multiple actions of high-density lipoprotein

  2008cited by this paper
• Seven challenges for nanomedicine.

  2008cited by this paper
• An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection.

  2008cited by this paper
• Mouse models for atherosclerosis and pharmaceutical modifiers.

  2007cited by this paper
• D-mannose-modified iron oxide nanoparticles for stem cell labeling.

  2007cited by this paper
• Renal clearance of quantum dots

  2007cited by this paper
• Acyl-CoenzymeA (CoA):Cholesterol Acyltransferase Inhibition in Rat and Human Aortic Smooth Muscle Cells Is Nontoxic and Retards Foam Cell Formation

  2004cited by this paper
• High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.

  2003cited by this paper
• Emerging importance of HDL cholesterol in developing high‐risk coronary plaques in acute coronary syndromes

  2003cited by this paper
• Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200475-JLR200

  2003cited by this paper
• From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

  2003cited by this paper
• From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

  2003cited by this paper
• ApoA-I Structure on Discs and Spheres

  2002cited by this paper
• Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.

  2001cited by this paper
• Atherosclerosis : Vascular biology

  2000cited by this paper
• A Detailed Molecular Belt Model for Apolipoprotein A-I in Discoidal High Density Lipoprotein*

  1999cited by this paper
• Cell cholesterol efflux: integration of old and new observations provides new insights.

  1999cited by this paper
• Mouse Models of Atherosclerosis

  1996cited by this paper
• Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor

  1996cited by this paper
• The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.

  1994cited by this paper
• [26] Electron microscopy of negatively stained lipoproteins

  1986cited by this paper
• Electron microscopy of negatively stained lipoproteins.

  1986cited by this paper
• Plasma lipoproteins: apolipoprotein structure and function.

  1984cited by this paper
• Interaction of bovine serum high density lipoprotein with mixed vesicles of phosphatidylcholine and cholesterol.

  1979cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper

• High-density lipoprotein-based nanoplatforms for macrophage-targeted diagnosis and therapy of atherosclerosis.

  2025cites this paper
• A Synthetic Nanoparticle to Mimic High-Density Lipoprotein for Reverse Cholesterol Transport.

  2025cites this paper
• Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations

  2022cites this paper
• Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies

  2022cites this paper
• The Janus of Protein Corona on nanoparticles for tumor targeting, immunotherapy and diagnosis.

  2022cites this paper
• Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering

  2021cites this paper
• Glyconanofluorides as Immunotracers with a Tunable Core Composition for Sensitive Hotspot Magnetic Resonance Imaging of Inflammatory Activity

  2021cites this paper
• Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology - A new chance for causative therapy?

  2021cites this paper
• Exploring the Therapeutic Potential of the Bioinspired Reconstituted High Density Lipoprotein Nanostructures.

  2021cites this paper
• Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy.

  2020cites this paper
• Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents

  2020cites this paper
• Lipoproteins-nanocarriers as a Promising Approach for Targeting Liver Cancer: Present Status and Application Prospects.

  2020cites this paper
• Nanophytomedicine Based Novel Therapeutic Strategies in Liver Cancer

  2020cites this paper
• High density lipoprotein mimicking nanoparticles for atherosclerosis

  2020cites this paper
• Bio-Mimetic Magnetic Nanostructures: A Theranostic Platform Targeting Lipid Metabolism and Immune Response in Lymphoma.

  2019cites this paper
• Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research

  2019influential citation
• Excretion and Clearance

  2018cites this paper
• 10 Molecular MRI of Atherosclerosis

  2018influential citation
• Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy

  2018cites this paper
• Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution.

  2018cites this paper
• High-Density Lipoprotein Nanobiologics for Precision Medicine.

  2018cites this paper
• Molecular Imaging with Spectral CT Nanoprobes

  2017cites this paper
• Recombinant high-density lipoproteins and their use in cardiovascular diseases.

  2017cites this paper
• High-Density Lipoprotein-like Magnetic Nanostructures (HDL-MNS): Theranostic Agents for Cardiovascular Disease

  2017cites this paper
• Theranostic nanoparticles for the management of inflammatory diseases and conditions

  2017cites this paper
• Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy

  2016cites this paper
• Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery.

  2016cites this paper
• Gold silver alloy nanoparticles (GSAN): an imaging probe for breast cancer screening with dual-energy mammography or computed tomography.

  2016cites this paper
• Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination.

  2016cites this paper
• Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

  2016cites this paper
• Quantitative Activity Measurements of Brown Adipose Tissue at 7 T Magnetic Resonance Imaging After Application of Triglyceride-Rich Lipoprotein 59Fe-Superparamagnetic Iron Oxide Nanoparticle: Intravenous Versus Intraperitoneal Approach

  2016cites this paper
• Modulation of Carbon Nanotubes' Perturbation to the Metabolic Activity of CYP3A4 in the Liver

  2016cites this paper
• High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

  2016cites this paper
• Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice.

  2016cites this paper
• Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging

  2015influential citation
• Reconstituted high density lipoprotein-based nanoparticles: an overview of applications in regenerative medicine, preparation, evaluation and future trends.

  2015cites this paper
• Efficacy and Hemotoxicity of Stealth Doxorubicin-Loaded Magnetic Nanovectors on Breast Cancer Xenografts.

  2015cites this paper
• Nanomedicines for Endothelial Disorders.

  2015cites this paper
• Spatial frequency analysis of high-density lipoprotein and iron-oxide nanoparticle transmission electron microscope image structure for pattern recognition in heterogeneous fields

  2014cites this paper
• Impact of Bionanointeractions of Engineered Nanoparticles for Nanomedicine

  2014cites this paper
• MR cholangiography demonstrates unsuspected rapid biliary clearance of nanoparticles in rodents: implications for clinical translation.

  2014cites this paper
• Application of functionalized nanoparticle for mass spectrometry.

  2014cites this paper
• Biological barriers and current strategies for modifying nanoparticle bioavailability.

  2014cites this paper
• Perturbation of physiological systems by nanoparticles.

  2014cites this paper
• Imaging macrophages with nanoparticles.

  2014cites this paper
• Nanodisco Balls: Control over Surface versus Core Loading of Diagnostically Active Nanocrystals into Polymer Nanoparticles

  2014cites this paper
• Anti-inflammatory mediators for molecular imaging of atherosclerosis

  2014cites this paper
• A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation

  2014cites this paper
• High-density lipoprotein is a nanoparticle, but not all nanoparticles are high-density lipoprotein

  2013cites this paper
• Design strategies of hybrid metallic nanoparticles for theragnostic applications

  2013cites this paper
• Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.

  2013cites this paper
• Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases

  2013influential citation
• Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins.

  2013cites this paper
• Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics.

  2013cites this paper
• Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality

  2013cites this paper
• Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery.

  2013influential citation
• Advances in Atherosclerotic Plaque Targeting , Imaging and Treatment Using Nanotechnology and Stem Cells Research

  2013cites this paper
• Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs

  2013cites this paper
• Fabrication of Spheroidal Microparticles from Biodegradable Polymers for Drug Delivery Applications

  2012cites this paper
• Design of nanovectors for therapy and imaging of cardiovascular diseases.

  2012cites this paper
• Tanshinone IIA-loaded reconstituted high density lipoproteins: Atherosclerotic plaque targeting mechanism in a foam cell model and pharmacokinetics in rabbits.

  2012cites this paper
• Synthesis and Characterization of Functionalized Magnetic Nanoparticles for the Detection of Pesticide

  2012cites this paper
• Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver

  2012cites this paper
• Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux.

  2012cites this paper
• Molecular MRI of Atherosclerosis

  2012influential citation
• Enhancement of HDL Formation and Normalization of Intravascular HDL Remodeling

  2011cites this paper
• Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model.

  2011cites this paper
• Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery.

  2011cites this paper
• Development and application of a multimodal contrast agent for SPECT/CT hybrid imaging.

  2011cites this paper
• Fluorescent Iron Oxide Nanoparticles for Molecular MR and Optical Imaging

  2011cites this paper
• Nanospheres and Applications to Cardiology: The Key to Future Success

  2011cites this paper
• Perspectives and opportunities for nanomedicine in the management of atherosclerosis

  2011cites this paper
• FMN-coated fluorescent iron oxide nanoparticles for RCP-mediated targeting and labeling of metabolically active cancer and endothelial cells.

  2011influential citation
• Advances in contrast media for vascular imaging of atherosclerosis

  2011cites this paper